Table 1.
Characteristic | Control group n=61 | IL-I group n=60 | P value |
---|---|---|---|
Age, mean ±SD | 52.4±4.2 | 51.7±4.9 | 0.27 |
Sex | 0.42 | ||
Female | 25 | 24 | |
Male | 36 | 36 | |
BMI, mean ±SD | 28±1.4 | 28.6±1.8 | 0.68 |
Smoker | 0.71 | ||
Never | 13 | 11 | |
Former | 31 | 37 | |
Current | 17 | 12 | |
Hypertension | 47 | 51 | 0.61 |
History of cardiovascular disease | 5 | 6 | 0.91 |
HDL-cholesterol, mean ±SD | 54.5±3.8 | 54.2±3.7 | 0.77 |
Comorbidities | |||
Peripheral neuropathy | 9 | 14 | 0.255 |
Diabetic retinopathy | 13 | 8 | 0.338 |
History of medication | |||
ACEI/ARB | 11 | 13 | 0.654 |
Spironolactone | 7 | 6 | 0.818 |